EICOSAPENTAENOIC ACID
5,8,11,14,17-Eicosapentaenoic acid
EICOSAPENTAENOIC ACID 列于欧盟 CosIng 清单,但本页尚未关联任何直接的附件记录。
按市场划分的监管证据
此处跟踪的 13 个市场均未导入该成分的规则。
这描述的是本清单,而非法律。没有已导入的规则并不能证明某成分获准使用:规则可能以其他名称或标识符存在,或存在于尚未在此导入的数据集中。
EICOSAPENTAENOIC ACID 的清单详情
INCI 名称
EICOSAPENTAENOIC ACID
INN 名称
icosapent
说明
5,8,11,14,17-Eicosapentaenoic acid
EICOSAPENTAENOIC ACID 的附件记录
关键数据
- SKIN CONDITIONING
Maintaining the skin in good condition.
- SKIN CONDITIONING - EMOLLIENT
Acting as lubricants on the skin surface providing the skin with a soft and smooth appearance.
化学身份与性质

Icosapent
All-cis-5,8,11,14,17-icosapentaenoic acid is an icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17. It has a role as a micronutrient, an antidepressant, an antineoplastic agent, an anticholesteremic drug, a nutraceutical, a mouse metabolite, a fungal metabolite and a Daphnia galeata metabolite. It is an omega-3 fatty acid and an icosapentaenoic acid. It is a conjugate acid of an all-cis-5,8,11,14,17-icosapentaenoate. — ChEBI
- IUPAC 名称
- (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
- 分子式
- C20H30O2
- 分子量
- 302.5 g/mol
- 精确质量
- 302.224580195 Da
- XLogP3
- 5.6
- 拓扑极性表面积
- 37.3 Ų
- 氢键供体
- 1
- 氢键受体
- 2
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:28364
- ChEMBL:CHEMBL460026
- EPA DTXSID:DTXSID9041023
- PubMed:29968805
- PubMed:21683321
- PubMed:20671299
- PubMed:15753205
- PubMed:15619630
- PubMed:15519495
- PubMed:11347965
来自其他科学数据库的证据
EMBL-EBI ChEBI
all-cis-5,8,11,14,17-icosapentaenoic acid
An icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17.
- 配方
- C20H30O2
- 平均质量
- 302.458 g/mol
- 单同位素质量
- 302.22458 Da
- 形式电荷
- 0
- icosapentaenoic acid — is a (CHEBI:36006)
- ω−3 fatty acid — is a (CHEBI:25681)
- antiviral agent — has role (CHEBI:22587)
- renoprotective agent — has role (CHEBI:231911)
- immunosuppressive agent — has role (CHEBI:35705)
- anti-obesity agent — has role (CHEBI:74518)
- micronutrient — has role (CHEBI:27027)
- nutraceutical — has role (CHEBI:50733)
- Daphnia galeata metabolite — has role (CHEBI:83038)
- anticholesteremic drug — has role (CHEBI:35821)
- mouse metabolite — has role (CHEBI:75771)
- antineoplastic agent — has role (CHEBI:35610)
- antidepressant — has role (CHEBI:35469)
- fungal metabolite — has role (CHEBI:76946)
- geroprotector — has role (CHEBI:176497)
- antirheumatic drug — has role (CHEBI:35842)
- anti-asthmatic agent — has role (CHEBI:65023)
- antipsychotic agent — has role (CHEBI:35476)
- antiviral agent — has role (CHEBI:22587)
- renoprotective agent — has role (CHEBI:231911)
- immunosuppressive agent — has role (CHEBI:35705)
- anti-obesity agent — has role (CHEBI:74518)
- micronutrient — has role (CHEBI:27027)
- nutraceutical — has role (CHEBI:50733)
- Daphnia galeata metabolite — has role (CHEBI:83038)
- anticholesteremic drug — has role (CHEBI:35821)
- mouse metabolite — has role (CHEBI:75771)
- antineoplastic agent — has role (CHEBI:35610)
- antidepressant — has role (CHEBI:35469)
- fungal metabolite — has role (CHEBI:76946)
- geroprotector — has role (CHEBI:176497)
- antirheumatic drug — has role (CHEBI:35842)
- anti-asthmatic agent — has role (CHEBI:65023)
- antipsychotic agent — has role (CHEBI:35476)
- cardiovascular drug — has role (CHEBI:35554)
- anticonvulsant — has role (CHEBI:35623)
- anti-inflammatory agent — has role (CHEBI:67079)
- gastrointestinal drug — has role (CHEBI:55324)
- icosapentaenoic acid — is a (CHEBI:36006)
- ω−3 fatty acid — is a (CHEBI:25681)
- all-cis-5,8,11,14,17-icosapentaenoate — is conjugate acid of (CHEBI:58562)
- 11421736 来源: PubMed
- 12549599 来源: PubMed
- 16643058 来源: PubMed
- 17420205 来源: PubMed
- 18459759 来源: PubMed
- 18638380 来源: PubMed
- 19036594 来源: PubMed
- 19054597 来源: PubMed
- 20014752 来源: PubMed
- 21118482 来源: PubMed
- 21274596 来源: PubMed
- 21903399 来源: PubMed
- 22260081 来源: PubMed
- 22822908 来源: PubMed
- 23920312 来源: PubMed
- 24108131 来源: PubMed
- 24238887 来源: PubMed
- 24351031 来源: PubMed
- 24387137 来源: PubMed
- 24389665 来源: PubMed
- 26784936 来源: PubMed
- 31483660 来源: PubMed
- 31618024 来源: PubMed
- 33378197 来源: PubMed
其他整理的名称
来自此来源的交叉引用
- CAS: 10417-94-4 — KEGG COMPOUND
- CAS: 10417-94-4 — ChemIDplus
- REGISTRY_NUMBER: 1714433 — Reaxys
- MANUAL_X_REF: 3174 — DrugCentral
- MANUAL_X_REF: C00000408 — KNApSAcK
- MANUAL_X_REF: C00001215 — KNApSAcK
- MANUAL_X_REF: C06428 — KEGG COMPOUND
- MANUAL_X_REF: D08061 — KEGG DRUG
- MANUAL_X_REF: DB00159 — DrugBank
- MANUAL_X_REF: EICOSAPENTAENOATE — MetaCyc
- MANUAL_X_REF: EPA — PDBeChem
- MANUAL_X_REF: HMDB0001999 — HMDB
- MANUAL_X_REF: LMFA01030759 — LIPID MAPS
映射方: Exact CAS cross-reference in the ChEBI compound record. 来源更新: 2018-03-05. 检索时间: 2026-08-31. 打开来源记录
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- LogP: 6.1 来源: DrugBank
- Physical Description: Liquid 来源: Human Metabolome Database (HMDB)
- Signal: Danger 来源: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] 来源: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 92 reports by companies from 1 notifications to the ECHA C&L Inventory.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录
科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。
其他来源的覆盖范围和匹配状态
| 来源 | 结果 | 已检查 |
|---|---|---|
| EMBL-EBI ChEBI | 精确匹配 | 2026-08-31 |
| NIH PubChem PUG-View | 精确匹配 | 2026-08-31 |
已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方 INCI 名称所述内容
The official label identifies a biological source material and its stated preparation or plant part.
- 根据措辞得出的身份类型
- biological_material
This structure is derived only from the official label wording. It does not establish composition, concentration, chemical equivalence, safety or regulatory permission.
欧盟官方成分名称证据
该成分名称与 2025 年欧盟官方通用成分名称词汇表完全匹配。
相关清单证据
配方功能重叠的成分
其他官方和科学来源
11 个可用于核查此身份的外部数据库
每个链接都会在该来源中搜索此身份。 各来源是什么及其法律效力
EICOSAPENTAENOIC ACID 在 CosIng 清单中的呈现方式
CosIng 清单将 EICOSAPENTAENOIC ACID 列为化妆品成分,本页将其关联到 0 条附件记录。清单条目记录名称和标识符,而附件记录显示该物质在欧盟化妆品法规中被禁用、限用或列入准用清单的情况。
在官方数据中,EICOSAPENTAENOIC ACID 还被标记了 2 项化妆品功能。功能标识描述预期用途,但不能取代在配方或标签工作之前对关联附件记录的监管审查。